Novartis AG is 211.6x more valuable than Harrow, Inc. by market capitalization ($283.13 B vs $1.34 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | HROW | NVS |
|---|---|---|
| Market cap | $1.34 B | $283.13 B |
| US-listed rank | #2417 | #47 |
| Revenue (latest FY) | $272.30M | - |
| Net income (latest FY) | -$5.14M | - |
| Net margin | -1.9% | - |
| SEC filings | 849 | 947 |
Novartis AG is 211.6x more valuable than Harrow, Inc. by market capitalization ($283.13 B vs $1.34 B).
Full pages: Harrow, Inc. and Novartis AG, or browse the full rankings.